maralixibat

maralixibat Mirum Pharmaceuticals Initiates Rolling Submission of a New Drug Application for Maralixibat for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome and Launches Expanded Access Program FOSTER CITY, Calif.–(BUSINESS WIRE)–Sep. 1, 2020– Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the development and commercialization of novel therapies for debilitating liver diseases today announced that it has submitted […]

Read more

Gigi Hadid Shared Her First Pregnancy Photos and They Are Stunning

Gigi Hadid has finally shared photos of her pregnancy and they are stunning. In a series of three posts, the model, who is expecting her first child with Zayn Malik, posted several styled shots showing off her stomach. In the first post, she wears a white drapey dress as she looks into the camera holding her belly. She captioned the […]

Read more

Tips on Getting the Most out of Virtual Therapy Sessions

When America first started locking down itself to contain the spread of coronavirus, therapists and their patients began virtual therapies using their cellphones and webcams to continue their sessions as tensions mounted across the nation. But as the lockdown continues, that brief virtual fix has now become a drawn-out arrangement as offices, cafes, and other places stay shut. Albeit virtual […]

Read more

HTX-011

Heron Therapeutics Announces FDA Extension of Review Period for NDA for HTX-011 for the Management of Postoperative Pain SAN DIEGO, Feb. 19, 2020 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that the U.S. Food and Drug Administration (FDA) has extended […]

Read more

ALKS 3831

Alkermes Announces U.S. Food and Drug Administration Acceptance of ALKS 3831 New Drug Application for Treatment of Schizophrenia and Bipolar I Disorder DUBLIN, Jan. 28, 2020 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) seeking approval of ALKS 3831 (olanzapine/samidorphan) for the treatment of schizophrenia and for the […]

Read more

selpercatinib

selpercatinib Lilly Receives FDA Priority Review for the Selpercatinib New Drug Application INDIANAPOLIS, Jan. 29, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has granted priority review for the New Drug Application (NDA) for selpercatinib (LOXO-292), for the treatment of patients with advanced RET fusion-positive non-small cell lung cancer (NSCLC), RET-mutant medullary thyroid cancer (MTC) and RET fusion-positive […]

Read more

Gene ID’d as potential therapeutic target for dementia in Parkinson’s

Dementia is one of the most debilitating consequences of Parkinson’s disease, a progressive neurological condition characterized by tremors, stiffness, slow movement and impaired balance. Eighty percent of people with Parkinson’s develop dementia within 20 years of the diagnosis, and patients who carry a particular variant of the gene APOE are at especially high risk. In new research, scientists at Washington University […]

Read more

When depression drives you to drink

When you drink, do you get depressed? Or is it the reverse: when you’re depressed, do you drink? An eight-year study of close to 1,300 teenagers by Canadian, American and German researchers appears to indicate the latter, and points to a solution: self-awareness. If people learn to recognize when they’re in a funk and deal with it, they’re less likely […]

Read more

Why nerve cells in the brain process information differently

The dentate gyrus is the “input point” for the hippocampus part of the brain. It transmits information from the short term memory to the long term. It consists of granule cells, which are especially dense in this area of the brain, and interneurons, which are linked up in the central or peripheral nervous system between several nerve cells and have […]

Read more

Controlling attention with brain waves

Having trouble paying attention? MIT neuroscientists may have a solution for you: Turn down your alpha brain waves. In a new study, the researchers found that people can enhance their attention by controlling their own alpha brain waves based on neurofeedback they receive as they perform a particular task. The study found that when subjects learned to suppress alpha waves […]

Read more
1 2 3 37